| Literature DB >> 24734174 |
Stefan Nilsson1, Berit Finnström2, Evalotte Mörelius3, Maria Forsner4.
Abstract
Needle fear is a common problem in children undergoing immunization. To ensure that the individual child's needs are met during a painful procedure it would be beneficial to be able to predict whether there is a need for extra support. The self-reporting instrument facial affective scale (FAS) could have potential for this purpose. The aim of this study was to evaluate whether the FAS can predict pain unpleasantness in girls undergoing immunization. Girls, aged 11-12 years, reported their expected pain unpleasantness on the FAS at least two weeks before and then experienced pain unpleasantness immediately before each vaccination. The experienced pain unpleasantness during the vaccination was also reported immediately after each immunization. The level of anxiety was similarly assessed during each vaccination and supplemented with stress measures in relation to the procedure in order to assess and evaluate concurrent validity. The results show that the FAS is valid to predict pain unpleasantness in 11-12-year-old girls who undergo immunizations and that it has the potential to be a feasible instrument to identify children who are in need of extra support to cope with immunization. In conclusion, the FAS measurement can facilitate caring interventions.Entities:
Year: 2014 PMID: 24734174 PMCID: PMC3964891 DOI: 10.1155/2014/628198
Source DB: PubMed Journal: Nurs Res Pract ISSN: 2090-1429
Figure 1The facial affective scale.
Figure 2Measurement points.
Expected level of pain unpleasantness using the FAS.
|
| Min. | Max. | Mean | SD | |
|---|---|---|---|---|---|
| Expected pain unpleasantness 1 | 31 | 0.17 | 0.75 | 0.56 | 0.20 |
| Expected pain unpleasantness 2 | 28 | 0.04 | 0.85 | 0.61 | 0.24 |
| Expected pain unpleasantness 3 | 32 | 0.04 | 0.85 | 0.61 | 0.22 |
The number and proportions of study participants who did or did not feel pain unpleasantness.
| Vaccination 1 | Vaccination 2 | Vaccination 3 | ||||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Expected FAS | ||||||
| FAS score ≥0.75 | 14/31 | 45% | 15/28 | 54% | 19/32 | 59% |
| FAS score ≤0.47 | 13/31 | 42% | 7/28 | 25% | 11/32 | 34% |
| Experienced FAS | ||||||
| FAS score ≥0.75 | 17/37 | 46% | 21/37 | 57% | 11/37 | 30% |
| FAS score ≤0.47 | 11/37 | 30% | 9/37 | 24% | 16/37 | 43% |
Descriptive statistics.
| Min. | Max. | Mean | SD | |
|---|---|---|---|---|
| First immunization | ||||
| Experienced FAS | 0.04 | 0.85 | 0.59 | 0.22 |
| Experienced VAS-A | 0 | 9 | 4.02 | 2.51 |
| Experienced VRSS | 0 | 4 | 1.56 | 1.03 |
| Second immunization | ||||
| Experienced FAS | 0.04 | 0.85 | 0.63 | 0.20 |
| Experienced VAS-A | 0 | 8.5 | 3.78 | 2.36 |
| Experienced VRSS | 0 | 4 | 1.51 | 1.15 |
| Third immunization | ||||
| Experienced FAS | 0.04 | 0.85 | 0.54 | 0.21 |
| Experienced VAS-A | 0 | 6.6 | 2.63 | 2.02 |
| Experienced VRSS | 0 | 3 | 1.19 | 0.94 |
The Pearson correlation test.
| Immunization | 1 | 2 | 3 |
|---|---|---|---|
| FAS | FAS | FAS | |
| VAS-A |
|
|
|
| VRSS |
|
|
|